MADD expression was determined by immunofluorescence staining using an exon 13L-specific antibody in three breast cancer cell lines (i.e. MCF-7, MDA-MB-231 and T47D cells) (Fig. 2A). This evidence concerns the gene MADD and breast carcinoma.